A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: MuCopilot mobile application.
- Who it may be relevant to
- Registry conditions: Cystic Fibrosis. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The study aims to assess the usability and safety of use of MuCopilot, a smartphone application that measures objective data on lung function, global exercise capacity and patient reported outcomes of patients with Cystic Fibrosis (CF). These data are collected during unsupervised digital tests performed in the patient's home environment between consultations. The primary objective is to validate the usability and safety of use, in order to assure that the patients use the medical device as intended without any unacceptable error of use and without unacceptable risk. The study will include 17 CF patients and will be conducted in France. They will participate in 1 inclusion visit and 1 visit in-clinic (1h30). Patients will be able to download the free MuCopilot mobile application. During the visit, patients will complete 3 digital tests in order to monitor CF functions (cough, dyspnea \& walking) and 1 symptom questionnaire.
Interventions
- Device MuCopilot mobile application
MuCopilot is a software as medical device with three digital tests, to measure patient's with CF, lung function, global exercise capacity and a questionnaire to address CF symptoms and impacts on some aspects of patient's life
Primary outcome measures
- Validation of usability (1) [Time frame: 2 hours]
- Validation of usability (2) [Time frame: 2 hours]
- Validation of no safety critical of use [Time frame: 2 hours]
- Validation of ease of use [Time frame: 2 hours]
Eligibility criteria
Inclusion criteria
- Aged ⩾ 18 years old
- Patients diagnosed with cystic fibrosis
- Enrolled in or benefiting of a Social Security program
- Having read the information sheet and signed the informed consent form
- Owning a personal smartphone which version is above 14 for IOS and 8 for Android included with a good internet connexion
- Able to read French and understand pictograms on a smartphone app
Exclusion criteria
- History of lung transplantation
- Pregnant women and women who are breastfeeding
- Any medical condition that could interfere with the proper conduct and results of the study (clinician's judgement)
- Illiterate in French
- Inability to use a smartphone or MuCopilot application
- Person under legal protection (including guardianship or curatorship)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
France · 1 center
- CRCM Mixte - Hôpital Charles Nicolle — Rouen
Identifiers
NCT: NCT06132048 · ADS-MuControl-Summative-2023